Trial Information

Summary: A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-label Extension Phase.

Allergan Inc., is conducting a study to evaluate the safety and efficacy of BOTOX^® as a study drug, in subjects that suffer from migraine headaches more than 15 or more days a month.

To qualify, you must:

• Be aged 18 to 65 years old
• Have been diagnosed with migraine headaches
• Have 15 or more headache days a month

You will not qualify if you:

• Are pregnant or nursing
• Have known allergies to BOTOX®
• Are currently taking an experimental drug or have within the last 30 days
• Have certain neurological muscle weakening disorders
• Are taking or have taken certain medications to prevent headache within 4 weeks prior to your first study visit, or are undergoing certain treatments for your condition
• Received previous treatment with or were immunized with the study drug or similar types of drugs

If you would like to learn more about participating in this study, please send an e-mail message using the form below.